Is a reduced estimated glomerular filtration rate a risk factor for stroke in patients with type 2 diabetes?

Hypertension Research

Volumn 32, Issue 5, 2009, Pages 381-386

  Bouchi, Ryotaro ^a   Babazono, Tetsuya ^a   Nyumura, Izumi ^a   Toya, Kiwako ^a   Hayashi, Toshihide ^a   Ohta, Mari ^a   Hanai, Ko ^a   Kiuchi, Yuka ^a   Suzuki, Kumi ^a   Iwamoto, Yasuhiko ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; AGED; ALBUMINURIA; ARTERY DISEASE; ARTICLE; BRAIN INFARCTION; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETIC RETINOPATHY; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; FEMALE; GLOMERULUS FILTRATION RATE; HAZARD RATIO; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK FACTOR; SUBARACHNOID HEMORRHAGE; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; AGED, 80 AND OVER; ALBUMINURIA; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; JAPAN; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; STROKE; YOUNG ADULT;

EID: 68249155088     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2009.30     Document Type: Article

References (35)

1. Kidney Disease Outcome Quality Initiative. K/DCQ1 clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 2002; 39 (Suppl 2): S1-S246.
2. Ninomiya T, Kiyohara Y, Kubo M, Tanizaki Y, Doi Y, Okubo K, Wakagawa Y, Hata J, Oishi Y, Shikata K, Yonemoto K, Hirakata H, Iida M. Chronic kidney disease and cardiovascular disease in a general Japanese population: The Hisayama Study. Kidney Int 2005; 68: 228-236.
3. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351; 2004: 1296-1305.
4. Keith DS, Nichols GA, Vullion CM, Brown JB, Smith DH. Longitudinal follow-up and outcomes among general population with chronic kidney disease in a large managed care organization. Arch Intern Med 2004; 164: 659-663.
5. Murray CJL, Lopez AD. Global Pattern of Cause of Death and Burden of Disease in 1990, with Projection to 2020-Investigating in Health Research and Development. Report of the Ad Hoc Committee on Health Research Relating to Future Intervention Options. WHO: Geneva, 1996.
6. Menotti A, Jacobs Jr DR, Blackburn H, Kromhout D, Nissine A, Nedeljkovic S, Buzina R, Mohacek I, Seccareccia F, Giampaoli S, Dontas A, Aravanis C, Toshima H. Twenty-five-year prediction of stroke deaths in the seven countries study: The role of blood pressure and its change. Stroke 1996; 27: 381-387.
7. Mulnier HE, Seaman HE, Raleigh VS, Soedamah-Muthu SS, Colhoun HM, Lawrenson RA, De Vries CS. Risk of stroke in people with type 2 diabetes in the UK: A study using the General Practice Research Database. Diabetologia 2006; 49: 2859-2865.
8. Wolf PA, D'Agostino RB, Belanger AJ, Kannel WB. Probability of stroke: A risk profile from the Framingham Study. Stroke 1991; 22: 312-318.
9. So WY, Kong AP, Ma RC, Ozaki R, Szeto CC, Chan NN, Ng V, Ho CS, Lam CW, Chow CC, Cockram CS, Chan JC, Tong PC. Glomerular filtration rate, cardiorenal endpoints, and all-cause-mortality in type 2 diabetic patients. Diabetes Care 2006; 29: 2046-2052.
10. Alberti KGMM, Zimmet P, for the WHO consultation. Definition, diagnosis, and classification of diabetes mellitus and its complications, part 2: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15: 539-553.
11. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, Hiratzka LF, Murphy WRC, Olin JW, Puschett JB, Rosenfield KA, Sacks D, Stanley JC, Taylor Jr LM, White CJ, White J, White RA. ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic). Circulation 2006; 113: E436-e465.
12. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, Kusek JW, Van Lente F. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006; 145: 247-254.
13. Imai E, Horio M, Nitta K, Yamagata K, Iseki K, Tsukamoto Y, Ito S, Makino H, Hishida A, Matsuo S. Modification of the Modification of Diet in Renal Disease (MDRD) Study equation for Japan. Am J Kidney Dis 2007; 50: 927-937.
14. American Diabetes Association. Nephropathy in diabetes. Diabetes Care 2004; 322: 531-536.
15. Weiner DE, Tighiouart H, Amin MG, Stark PC, MacLeod B, Griffith JL, Salem DN, Levey AS, Sarnak MJ. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: A pooled-analysis of community-based studies. J Am Soc Nephrol 2004; 15: 1307-1315.
16. Rahman M, Pressel S, Davis BR, Nwachuku C, Wright Jr JT, Whelton PK, Barzilay J, Batuman V, Eckfeldt JH, Farber MA, Franklin S, Henriquez M, Kopyt N, Louis GT, Saklayen M, Stanford C, Walworth C, Ward H, Wiegmann T, ALLHAT Collaborative Research Group. Cardiovascular outcomes in high-risk hypertensive patients stratified by baseline glomerular filtration rate. Ann Intern Med 2006; 144: 172-180.
17. Schneider CA, Ferrannini E, Defronzo R, Scherathaner G, Yates J, Erdmann E. Effect of pioglitazone on cardiovascular outcome in diabetes and chronic kidney disease. J Am Soc Nephrol 2008; 19: 182-187.
18. Anavekar NS, Gans DJ, Berl T, Rohde RD, Couper W, Bhaumik A, Hunsicker LG, Rouleau JL, Lewis JB, Vanhille P, Locatelli F, Goldhaber S, Lewis EJ, Pfeffer MA. Predictors of cardiovascular events in patients with type 2 diabetic nephropathy and hypertension; a case for albuminuria. Kidney Int 2004; 92: S50-S55.
19. Eijkelkamp WB, Zhang Z, Brenner BM, Cooper ME, Devereux RB, Dahlof B, Ibsen H, Keane WF, Lindholm LH, Olsen MH, Parving HH, Remuzzi G, Shahinfar S, Snapinn SM, Wachtell K, de Zeeuw D. Renal function and risk for cardiovascular events in type 2 diabetic patients with hypertension: the RENAAL and LIFE studies. J Hypertens 2007; 25: 871-876.
20. Special Report From the National Institute of Neurological Disorders and Stroke. Classification of cerebrovascular diseases III. Stroke 1990; 21: 637-676.
21. Cohen AB, Taylor RA, Steven R, Messd SR, Kasner SE. Serum creatinine does not improve early classification of ischemic stroke caused by small artery occlusion. J Stroke Cerebrovasc Dis 2006; 15: 96-100.
22. Dinneen SF, Gerstein HC. The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus: A systematic overview of the literature. Arch Intern Med 1997; 157: 1413-1418.
23. Neamer NB, Coull BM, Clark WM, Wynn M. Microalbuminuria in ischemic stroke. Arch Neurol 1999; 56: 699-702.
24. Yuyun MF, Khaw KT, Luben R, Welch A, Bingham S, Day NE, Wareham NJ. Microalbuminuria and stroke in a British population: The European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) population study. J Intern Med 2004;255: 247-255.
25. Paisley KE, Beaman M, Tooke JE, Mohamed-Ali V, Lowe GD, Shore AC. Endothelial dysfunction and inflammation in asymptomatic proteinuria. Kidney Int 2003; 63: 624-633.
26. Bianchi S, Bigazzi R, Campese VM. Microalbuminuria in essential hypertension: Significance, pathophysiology, and therapeutic implications. Am J Kidney Dis 1999; 34: 973-995.
27. Shankar A, Klein R, Moss SE, Klein BE, Wong TY. The relationship between albuminuria and hypercholesterolemia. J Nephrol 2004; 17: 658-665.
28. Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V, Whelton PK, He J. The metabolic syndrome and chronic kidney disease in US adults. Ann Intern Med 2004; 140: 167-174.
29. Hanai K, Babazono T, Iwamoto Y. Renal manifestations of metabolic syndrome in type 2 diabetes. Diabetes Res Clin Pract 2008; 79 318-324.
30. Fenq L, Matsumoto C, Schwartz A, Schmidt DM, Pile-Spellman J. Chronic vascular inflammation in patients with type 2 diabetes: Endothelial biopsy and RT-PCR analysis. Diabetes Care 2005; 28: 379-384.
31. Juhan-Vague I, Alessi MC, Vague P. Thrombogenic and fibrinolytic factors and cardiovascular risk in non-insulin-dependent diabetes mellitus. Ann Med 1996; 28: 371-380.
32. Soinio M, Marniemi J, Laakso M, Lehto S, Rönnemaa T. Elevated plasma homocysteine level is an independent predictor of coronary heart disease events in patients with type 2 diabetes mellitus. Ann Intern Med 2004; 140: 94-100.
33. Fliser D, Kronenberg F, Kielstein JT, Morath C, Bode-Boger SM, Haller H, Ritz E. Asymmetrical dimethylarginine and progression of chronic kidney disease: The mild to moderate kidney disease study. J AM Soc Nepnrol 2005; 16; 2456-2461.
34. Hermans MM, Henry RM, Dekker JM, Nijpel G, Heine RJ, Stehouwer CD. Albuminruia, but not estimated glomerular filtration rate, is associated with maladaptive arterial remodeling: The Hoorn Study. J Hypertens 2008; 26: 791-797.
35. Babazono T, Takahashi C, Iwamoto Y. Definition of microalbuminuria in first-morning and random spot urine in diabetic patients. Diabetes Care 2004; 27: 1838-1839.